On the public citation graph

Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China: a cross-sectional study

https://doi.org/10.1101/2020.06.16.20132423
0 signed · 50 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.8279openalex-snapshot
Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
inferredcites →https://doi.org/10.1002/jmv.25727openalex-snapshot
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
inferredcites →https://doi.org/10.1002/jmv.25904openalex-snapshot
Serological tests facilitate identification of asymptomatic SARS‐CoV‐2 infection in Wuhan, China
inferredcites →https://doi.org/10.1002/jmv.25989openalex-snapshot
A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: A possible reason underlying different outcome between sex
inferredcites →https://doi.org/10.1016/j.cca.2020.03.009openalex-snapshot
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020
inferredcites →https://doi.org/10.1016/j.cegh.2021.100747openalex-snapshot
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study
inferredcites →https://doi.org/10.1016/j.ijsu.2020.03.002openalex-snapshot
An Invited Commentary on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)": Emergency or new reality?
inferredcites →https://doi.org/10.1016/j.jacr.2020.03.006openalex-snapshot
Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1016/j.jaut.2020.102433openalex-snapshot
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
inferredcites →https://doi.org/10.1016/s0140-6736(16)30164-7openalex-snapshot
Use of serological surveys to generate key insights into the changing global landscape of infectious disease
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1016/s0140-6736(20)30211-7openalex-snapshot
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
inferredcites →https://doi.org/10.1016/s0140-6736(20)31304-0openalex-snapshot
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
inferredcites →https://doi.org/10.1016/s0140-6736(20)31483-5openalex-snapshot
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
inferredcites →https://doi.org/10.1016/s1473-3099(20)30196-1openalex-snapshot
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
inferredcites →https://doi.org/10.1016/s2666-5247(20)30053-7openalex-snapshot
Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study
inferredcites →https://doi.org/10.1016/s2666-5247(20)30055-0openalex-snapshot
Population serology for SARS-CoV-2 is essential to regional and global preparedness
inferredcites →https://doi.org/10.1038/s41467-020-15562-9openalex-snapshot
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
inferredcites →https://doi.org/10.1038/s41467-020-17318-xopenalex-snapshot
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
inferredcites →https://doi.org/10.1038/s41586-020-2008-3openalex-snapshot
A new coronavirus associated with human respiratory disease in China
inferredcites →https://doi.org/10.1038/s41591-020-0949-6openalex-snapshot
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
inferredcites →https://doi.org/10.1038/s41591-020-1058-2openalex-snapshot
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
inferredcites →https://doi.org/10.1056/nejmoa2001017openalex-snapshot
A Novel Coronavirus from Patients with Pneumonia in China, 2019
inferredcites →https://doi.org/10.1056/nejmoa2002032openalex-snapshot
Clinical Characteristics of Coronavirus Disease 2019 in China
inferredcites →https://doi.org/10.1056/nejmoa2006100openalex-snapshot
Spread of SARS-CoV-2 in the Icelandic Population
inferredcites →https://doi.org/10.1080/22221751.2020.1729071openalex-snapshot
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
inferredcites →https://doi.org/10.1093/cid/ciaa344openalex-snapshot
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
inferredcites →https://doi.org/10.1093/cid/ciaa849openalex-snapshot
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a112510openalex-snapshot
ESTIMATING PREVALENCE FROM THE RESULTS OF A SCREENING TEST
inferredcites →https://doi.org/10.1101/2020.03.24.20042382openalex-snapshot
Viral Kinetics and Antibody Responses in Patients with COVID-19
inferredcites →https://doi.org/10.1101/2020.05.11.20092916openalex-snapshot
Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
inferredcites →https://doi.org/10.1101/2020.05.11.20098442openalex-snapshot
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak
inferredcites →https://doi.org/10.1126/science.abb4218openalex-snapshot
The effect of human mobility and control measures on the COVID-19 epidemic in China
inferredcites →https://doi.org/10.1126/science.abc3517openalex-snapshot
Estimating the burden of SARS-CoV-2 in France
inferredcites →https://doi.org/10.2807/1560-7917.es.2020.25.10.2000180openalex-snapshot
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
inferredcites →https://doi.org/10.3201/eid2702.201960openalex-snapshot
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
inferredcites →https://doi.org/10.3390/diagnostics10050319openalex-snapshot
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
inferredcites →https://doi.org/10.3390/v12050513openalex-snapshot
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
inferredcites →https://doi.org/10.7326/m20-0504openalex-snapshot
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/s11427-020-1859-yopenalex-snapshot
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
inferred← citeshttps://doi.org/10.1016/j.cll.2021.10.005openalex-snapshot
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
inferred← citeshttps://doi.org/10.1016/j.cmi.2020.09.044openalex-snapshot
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
inferred← citeshttps://doi.org/10.1016/j.ijid.2020.12.065openalex-snapshot
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
inferred← citeshttps://doi.org/10.1016/s2214-109x(21)00026-7openalex-snapshot
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1017/s0950268821002405openalex-snapshot
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
inferred← citeshttps://doi.org/10.1093/ije/dyac178openalex-snapshot
Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data
inferred← citeshttps://doi.org/10.1093/jtm/taaa135openalex-snapshot
SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China
inferred← citeshttps://doi.org/10.1371/journal.pone.0269104openalex-snapshot
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
inferred← citeshttps://doi.org/10.21931/rb/2020.05.03.21openalex-snapshot
Pruebas rápidas para COVID-19, la mejor alternativa para Ecuador
inferred← citeshttps://doi.org/10.2471/blt.20.265892openalex-snapshot
Infection fatality rate of COVID-19 inferred from seroprevalence data
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.